According to the report Latin America Nuclear Imaging Industry was worth $0.99 billion in 2016 and estimated to be growing at a CAGR of 7.99%, to reach $1.46 billion by 2021.
- Advertising -
Nuclear imaging Industry is showing strong growth predominantly in the cardiac sector, amid the growing attention towards cardiac disease deterrence and treatment.
Browse Market data tables and in-depth TOC of the Latin America Nuclear Imaging Industry to 2021 @ www.marketdataforecast.com/market-…ging-market-1627/
Nuclear imaging is generally utilized for cardiovascular and oncology applications. This technology allows doctors to formulate the appropriate alignment of radiation beams for the treatment of disease with sound accuracy.
- Advertising -
For instance, positron emission tomography (PET) imaging allows doctors to recognize chemical and physiologic variations in targeted tissues.
The growth of the Latin America Nuclear Imaging Industry is mainly driven by factors such as an increasing utilization of SPECT and PET examination in radiopharmaceuticals, rise in cognizance for prompt diagnosis, increasing frequency of cardiac diseases, and improving healthcare infrastructure in this region. However, factors such as costly procedures & equipment, shortage of supplies, and logistical difficulties are hindering the growth of the Industry in this region.
Free sample of the report is available @ www.marketdataforecast.com/market-…27/request-sample
The Latin America Nuclear Imaging Industry is segmented based on Diagnostic Technologies and Application. The Industry for Nuclear Imaging, on the basis of Diagnostic Technologies is segmented into PET Radioisotopes and SPECT Radioisotopes.
PET Radioisotopes are further segmented into Rubidium-82, Fluorine-18, whereas SPECT Radioisotopes are further segmented into Thallium-201, Technetium-99m, Xenon-133, and Iodine-123. On the basis of Application, the Nuclear Imaging Industry is segmented into PET and SPECT.
PET is further segmented into Cardiology, Oncology, and Neurology, whereas SPECT is segmented into Lymphoma, Neurology, Cardiology, and Thyroid. PET is mainly being utilized in oncology due to superior quality of imaging; Whereas SPECT is used in the cardiology section accounting for almost 80% of the entire cardiology Industry share.
Latin America Industry region includes countries such as Brazil, Mexico, and Rest of Latin America. The huge rise in spending in the healthcare division has increased the demand for Nuclear Imaging devices.
Brazil spends nearly 45% of their total expenditure on healthcare, whereas Argentina spends about 20%. Brazil is one of the largest Industrys in this region followed by Mexico, Chile, Columbia, which are also intensifying their investments in the Nuclear Imaging Industry.
Inquire about report @ www.marketdataforecast.com/market-…rket-1627/inquire
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Latin America Nuclear Imaging Industry: Segmentation
- Diagnostic Technologies
- o PET Radioisotopes
- o SPECT Radioisotopes
- o PET
- o SPECT
- Rest of Latin America
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Access report @ www.marketdataforecast.com/market-…/request-discount
Companies are showing a strong interest in enhancing image quality by developing new technologies and creating new devices or novel techniques to achieve images with higher spatial resolution. The major companies dominating the Nuclear Imaging Industry in this region are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co.
(healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: